Absence of inhibitory tumor metabolism: high serum lactate dehydrogenase concentrations correlate with poor outcome to anti-CTLA-4 and anti-PD-1 antibody immunotherapy [177]. The gene discussed is PDCD1; the disease is neoplasm.